Shares of Eli Lilly & Co. were headed for their worst day ... You can follow him on Twitter @TomiKilgore.

U.S. stock futures point higher ahead of closely watched CPI report, JPMorgan Chase stock rises on better-than-expected results, and economists expect annual inflation to have risen in December.

"Investors who sold Twitter common stock during this period did so at artificially low prices and thus suffered substantial economic harm," the regulator added. Musk's lawyer Alex Spiro reportedly ...

CEO Elon Musk over his purchase of Twitter; and Eli Lilly (LLY) stock is in focus after plunging yesterday on lower revenue projections. Here's what investors need to know today. 1. US Stock ...

Biotech stock Halozyme Therapeutics is climbing back in constructive form from a severe drop in November. Shares got a boost after the drug-delivery developer reiterated its 2024 forecast and raised ...

Eli Lilly ( LLY 3.89%) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in ...

It turns out that the anti-obesity space isn't growing as fast as Eli Lilly or analysts anticipated, resulting in ...

I think Eli Lilly and Company's stock correction may be ending as demand for key drugs Zepbound and Mounjaro remains strong, despite recent sales guidance cuts. The company's high valuation ...

Eli Lilly (LLY) closed the latest trading day at $804.99, indicating a -0.39% change from the previous session's end. The stock trailed the S&P 500, which registered a daily gain of 0.92%.